Medicament for treating perimenopausal hectic fever and recovering menstrual cycle and use method thereof

• Main Authors: KURUS NATALIE VITALI, ELLISTRATOVA, TATYANA VLADIMIROVNA, KRUTIAKOV EVGENIJ NIKOLAEVICH, KHOMYAKOVA IRINA VLADIMIROVNA, ELSTRATOVA, SVETLANA DMITRIEVNA, FEDOROV ANDREY VYACHESLAVOVICH, ELISTRATOVA PEGGY DMITRIEVNA, KOUZMINA ELENA NIKOLAEVNA, ELISTRATOV KONSTANTIN GENNADIEVICH, STRUKOV, VADIM IVANOVICH, KURRUS ANDREW NICHOLAS, ELISTERATOVA, JULIA, A, ANDREEVA ELENA S, TRIFONOV VIACHESLAV NIKOLAEVICH, PETROVA ELENA VLADIMIROVNA, PROKHOROV MIKHAIL DMITRIEVICH, ELISTRATOV GENNADIY MIKHAILOVICH
• Format: Patent
• Language: Chinese; English
• Published: 08.04.2022
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The present invention relates to agents and methods for treating hectic fever and restoring perimenopausal menstrual cycle. The claimed medicament comprises beta-alanine, an HDBA organic complex, glycine, one or more medicinal plants containing at least 1 mg/g of phytoestrogen, and excipients. The method comprises oral and/or sublingual administration of the claimed agent in a dose of from 500 mg to 1.5 g, 1-3 times per day, for up to 3 years. The medicine promotes normalizing of the menstrual cycle and relieving of hectic fever, not only can safely normalize the level of estrogen, but also can safely normalize the concentration of androgen, and even can obviously relieve the most serious symptom of perimenopause, namely hectic fever, by reducing the frequency and the strength of the estrogen level and the androgen concentration. 本发明涉及用于治疗潮热和恢复围绝经期月经周期的药剂和方法。要求保护的药剂包含：β-丙氨酸、HDBA有机复合物、甘氨酸、一种或多种含有至少1mg/g植物雌激素的药用植物和辅料。该方法包括以500mg至1.5g的剂量口服和/或舌下施用要求保护的药剂，每天1-3次，持续长达3年。上述药物促进月经周期的正常化和潮热的缓解，不仅可以使雌激素的水平还可以使雄激素的浓度安全地